Last updated: May 13, 2025
Sponsor: Trieu, Nguyen Thi, M.D.
Overall Status: Completed
Phase
4
Condition
Uterine Fibroids
Sarcoma (Pediatric)
Desmoid Tumors
Treatment
SB-UF Placebo
SB-UF
Clinical Study ID
NCT04762316
Removal the Uterine Fibroids
Ages 18-40 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Procedure to the treatment of fibroids in pregnancy and in women desiring futurefertility.
Exclusion
Exclusion Criteria:
- Subserosal fibroids may be pedunculated hanging from a stalk inside or outside theuterus.
Study Design
Total Participants: 66
Treatment Group(s): 2
Primary Treatment: SB-UF Placebo
Phase: 4
Study Start date:
January 01, 2019
Estimated Completion Date:
February 01, 2021
Study Description
Connect with a study center
Saigon Biopharma LLC
Wilmington, Delaware 19801-6601
United StatesSite Not Available
Saigon Biopharma Company Limited
Ho Chi Minh City, 700000
VietnamSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.